isosorbide dinitrate has been researched along with Hypertension, Portal in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (15.63) | 18.7374 |
1990's | 30 (46.88) | 18.2507 |
2000's | 21 (32.81) | 29.6817 |
2010's | 3 (4.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Hao, JH; Kong, DR; Li, P; Ma, C; Wang, JG; Wang, M; Xu, JM; Zhang, L | 1 |
Alvarado, E; Aracil, C; Ardevol, A; Colomo, A; Concepción, M; Graupera, I; Guarner, C; Hernandez-Gea, V; Miñana, J; Pavel, O; Poca, M; Puente, Á; Reñe, JM; Torras, X; Villanueva, C | 1 |
Dubey, S; Jha, SK; Kumar, A; Sarin, SK; Sharma, BC; Sharma, P; Tyagi, P | 1 |
Schepke, M | 1 |
Chen, WC; Lo, GH; Wang, HM; Yu, HC | 1 |
Chen, GH; Wu, CY; Yeh, HZ | 1 |
Alric, L; Barange, K; Bureau, C; Morales, J; Payen, JL; Péron, JM; Sanchez, J; Vinel, JP | 1 |
Fleig, WE | 1 |
Abraldes, JG; Bosch, J; Garcia-Pagan, JC; Rodés, J; Tarantino, I; Turnes, J | 1 |
Blendis, L; Lurie, Y; Oren, R | 1 |
Aracil, C; Balanzó, J; González, B; Guarner, C; Kolle, L; López-Balaguer, JM; Miñana, J; Soriano, G; Villanueva, C | 1 |
Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Yang, YY | 1 |
Geĭnits, AV; Sapozhkova, LP; Sergienko, VB; Tadzhiev, IIa; Tadzhieva, NI; Topchiashvili, ZA; Tsodikov, GV | 1 |
Bolondi, L; Donati, G; Gaiani, S; Gramantieri, L; Leoni, S; Mancini, M; Piscaglia, F | 1 |
Balas, BI; Diculescu, M; Orban Schiopu, AM | 1 |
Balanzo, J; Cusso, X; Gallego, A; Gonzalez-Suarez, B; Guarner, C; Minana, J; Sainz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
Garrido, A; Garzón, M; Grilo, I; Iglesias, A; Márquez, JL; Peiró, J | 1 |
Laleman, W; Nevens, F | 1 |
Irisawa, A; Kasukawa, R; Obara, K; Ohira, H; Saito, A; Sakamoto, H; Takiguchi, F | 1 |
Barberà, JA; Burgos, F; Melgosa, MT; Pizarro, S; Ricci, GL; Roca, J; Rodriguez-Roisin, R; Valera, JL | 1 |
Bosch, J; De Gottardi, A; Garcia-Pagan, JC | 1 |
Hallemans, R; Mélot, C; Mols, P; Naeije, R; Reding, P | 1 |
Bhatia, R; Kulhalli, PM; Mahajani, SS; Nanivadekar, SA; Sawant, P | 1 |
Bellon, S; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Calès, P; Oberti, F | 1 |
Bolognesi, M; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Hori, N; Itoh, Y; Kashima, K; Mori, T; Okanoue, T; Sawa, Y; Takami, S | 1 |
Bosch, J; Cabré, E; Feu, F; Galán, A; García Pagán, JC; Gassull, MA; Morillas, RM; Planas, R; Quer, JC | 1 |
Bouchier, IA; Grose, RD; Hayes, PC; Plevris, JN; Redhead, DN | 1 |
Abbati, G; Cioni, G; Cristani, A; D'Alimonte, P; Romagnoli, R; Tincani, E; Ventura, E; Ventura, P; Vignoli, A | 1 |
Hayes, PC; Jones, AL | 1 |
Backhouse, C; Barrientos, C; Bresky, G; Fluxá, F; Iturriaga, H; Palma, M; Ruiz, M; Silva, G | 1 |
Bessone, F; Bordato, J; Gamen, M; Palazzi, J; Picabea, E; Pozzoli, L; Sarano, H; Tanno, H; Villavicencio, R; Vorobioff, J | 1 |
Arroyo, V; Bosch, J; Claria, J; Feu, F; García-Pagán, JC; Ginès, A; Ginès, P; Rivera, F; Ruiz del Arbol, L; Salmerón, JM | 1 |
Bordas, JM; Bosch, J; Escorsell, A; Feu, F; García-Pagán, JC; Luca, A; Rodés, J | 1 |
Angeli, P; Bolognesi, M; Bombonato, G; Enzo, E; Gatta, A; Marin, R; Merkel, C; Sacerdoti, D | 1 |
Groszmann, RJ | 1 |
Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Albillos, A; Bandi, JC; Bosch, J; Cacho, G; Calleja, JL; Escartín, P; Escorsell, A; García-Pagán, JC; Iborra, J; Pérez-Paramo, M | 1 |
Burroughs, AK; Chin, J; Greenslade, L; McCormick, PA; McIntyre, N; Patch, D | 1 |
Hong, CY; Hou, MC; Huang, YT; Lee, SD; Lin, HC; Tsai, JF | 1 |
Chang, FY; Cheng, YR; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Tsai, YT | 1 |
Amodio, P; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Mazzaro, C; Merkel, C; Sacerdoti, D; Sebastianelli, G; Torboli, P | 1 |
Bosch, J | 1 |
Angrill, J; Barberà, JA; Bosch, J; García-Pagán, JC; Ribas, J; Roca, J; Rodriguez-Roisin, R | 1 |
Bellini, B; Bighin, R; Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Gamen, M; Picabea, E; Villavicencio, R; Vorobioff, J | 1 |
Cervinka, J; Drazná, E; Jedlicka, J; Petrtýl, J; Vrana, J | 1 |
Andreev, NG; Maev, IV; Vorob'ev, LP | 1 |
Alvarez, D; Lennie, A; Levi, D; Mastai, R; Soifer, G; Terg, R | 1 |
Bosch, J; Feu, F; García-Pagán, JC; Rodés, J | 1 |
Lebrec, D; Moreau, R | 1 |
Bosch, J; Bru, C; Feu, F; García-Pagán, JC; Navasa, M; Rodés, J; Ruiz del Arbol, L | 1 |
Bosch, J; Bru, C; Garcia-Pagán, JC; Navasa, M; Pizcueta, P; Rodés, J | 1 |
Abraham, P; Bhatia, SJ; Deshmukh, H; Jagasia, DH; Kothari, RH; Shah, AV; Vontivillu, JA | 1 |
Hallemans, R; Lejeune, P; Melot, C; Mols, P; Naeije, R | 1 |
Bosch, J; Chesta, J; Navasa, M; Rodés, J | 1 |
Blei, AT; Fung, HL; Ganger, D; Groszmann, R | 1 |
Brodanová, M; Cervinka, J; Kaláb, M; Kordac, V; Marecek, Z; Munclinger, M; Ort, J; Perlík, F; Petrtýl, J; Tesar, V | 1 |
Hayes, PC; Westaby, D; Williams, R | 1 |
Faruqui, A; Qureshi, H; Zuberi, SJ | 1 |
Bazzerla, G; Bolognesi, M; Finucci, G; Gatta, A; Merkel, C; Sacerdoti, D; Zuin, R | 1 |
Cervinka, J; Chmel, J; Horejsí, A; Kaláb, M; Kodadová, J; Kordac, V; Marecek, Z; Perlík, F | 1 |
Barton, JR; Freeman, JG; Record, CO | 1 |
8 review(s) available for isosorbide dinitrate and Hypertension, Portal
Article | Year |
---|---|
[Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hormones; Humans; Hypertension, Portal; Infection Control; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Lypressin; Portal Pressure; Secondary Prevention; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents | 2006 |
Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Randomized Controlled Trials as Topic; Sclerotherapy; Secondary Prevention; Treatment Outcome | 2008 |
[Portal hypertension: value of combination of nitrate derivatives and beta blockers for better prevention?].
Topics: Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Placebos; Propranolol | 1995 |
Organic nitrates in portal hypertension.
Topics: Animals; Collateral Circulation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Nitrates; Nitroglycerin; Vasodilator Agents | 1994 |
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Nitrovasodilators and portal hypertension.
Topics: Humans; Hypertension, Portal; Isosorbide Dinitrate; Nitroglycerin; Vasodilator Agents | 1990 |
Organic nitrates in portal hypertension.
Topics: Animals; Humans; Hypertension, Portal; Isosorbide Dinitrate; Nitroglycerin; Splanchnic Circulation | 1988 |
28 trial(s) available for isosorbide dinitrate and Hypertension, Portal
Article | Year |
---|---|
Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis.
Topics: Adult; China; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Male; Middle Aged; Portal Pressure; Propranolol; Schistosomiasis; Time Factors; Treatment Outcome; Vasodilator Agents | 2013 |
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Recurrence; Spain | 2017 |
Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence.
Topics: Adult; Combined Modality Therapy; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Circulation; Male; Propranolol; Risk Factors; Secondary Prevention; Vasodilator Agents; Venous Pressure | 2009 |
Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Chi-Square Distribution; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Propanolamines; Proportional Hazards Models; Secondary Prevention; Vasodilator Agents | 2012 |
"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding.
Topics: Adult; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Male; Middle Aged; Propranolol; Secondary Prevention; Treatment Outcome; Vasodilator Agents; Venous Pressure | 2002 |
Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Ascites; Esophageal and Gastric Varices; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nadolol; Prognosis | 2004 |
Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
Topics: Antihypertensive Agents; Carbazoles; Carvedilol; Drug Therapy, Combination; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propanolamines; Propranolol; Vasodilator Agents | 2004 |
[Comparative effectiveness of different methods of diagnosis and correction of impaired portal circulation].
Topics: Antihypertensive Agents; Humans; Hypertension, Portal; Isosorbide Dinitrate; Laser Therapy; Liver Cirrhosis; Propranolol; Ultrasonography, Doppler; Vasodilator Agents | 2004 |
Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
Topics: Aged; Blood Flow Velocity; Double-Blind Method; Fasting; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Portal Vein; Time Factors; Treatment Outcome; Vasodilator Agents | 2004 |
Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis.
Topics: Adrenergic beta-Antagonists; Bacterial Infections; Community-Acquired Infections; Drug Therapy, Combination; Epidemiologic Methods; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Peritonitis; Sclerotherapy; Secondary Prevention; Vasodilator Agents | 2006 |
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Topics: Administration, Oral; Adult; Aged; Blood Flow Velocity; Blood Pressure; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kidney; Liver; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Middle Aged; Nadolol; Pulsatile Flow; Splanchnic Circulation; Ultrasonography, Doppler, Color; Vascular Resistance; Vasodilator Agents | 1995 |
[Portal hypertension: value of combination of nitrate derivatives and beta blockers for better prevention?].
Topics: Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Placebos; Propranolol | 1995 |
Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
Topics: Adult; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Renal Circulation; Splanchnic Circulation; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1994 |
Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
Topics: Aldosterone; Analysis of Variance; Body Water; Chi-Square Distribution; Dinoprostone; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Portal; Inulin; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Propranolol; Renin; Splanchnic Circulation; Vasodilator Agents | 1994 |
Duplex Doppler ultrasonographic comparison of the effects of propranolol and isosorbide-5-mononitrate on portal hemodynamics.
Topics: Delayed-Action Preparations; Double-Blind Method; Drug Monitoring; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Splanchnic Circulation; Ultrasonography | 1993 |
Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
Topics: Blood Pressure; Body Weight; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kidney; Kidney Function Tests; Liver Circulation; Male; Middle Aged; Propranolol; Time Factors; Vascular Resistance | 1993 |
Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Topics: Aged; Blood Pressure; Double-Blind Method; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Splanchnic Circulation; Vasodilator Agents; Venous Pressure | 1996 |
Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Hepatic Artery; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Nadolol; Vasodilator Agents | 1997 |
Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension, Portal; Isosorbide Dinitrate; Propranolol; Vasodilator Agents | 1997 |
Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
Topics: Adrenergic beta-Antagonists; Catheterization, Peripheral; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hepatic Veins; Humans; Hypertension, Portal; Isosorbide Dinitrate; Linear Models; Liver Cirrhosis; Male; Middle Aged; Nadolol; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1998 |
Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepatic Veins; Humans; Hypertension, Portal; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Propranolol; Vasodilator Agents; Venous Pressure | 1998 |
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Randomized Controlled Trials as Topic | 2000 |
[Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
Topics: Adult; Aged; Antihypertensive Agents; Humans; Hypertension, Portal; Hypertension, Pulmonary; Isosorbide Dinitrate; Liver Cirrhosis; Middle Aged; Nifedipine; Propranolol | 1991 |
Noninvasive measurement of portal venous blood flow in patients with cirrhosis: effects of physiological and pharmacological stimuli.
Topics: Adult; Eating; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Observer Variation; Portal Vein; Regional Blood Flow; Ultrasonography | 1991 |
Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
Topics: Aged; Drug Therapy, Combination; Female; Hemodynamics; Hepatic Veins; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Propranolol; Venous Pressure | 1991 |
Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
Topics: Administration, Oral; Aged; Blood Pressure; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Nitroglycerin; Placebos; Time Factors | 1990 |
Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Splanchnic Circulation | 1989 |
Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis.
Topics: Humans; Hypertension, Portal; Isosorbide Dinitrate; Labetalol; Liver Cirrhosis; Venous Pressure; Verapamil | 1985 |
29 other study(ies) available for isosorbide dinitrate and Hypertension, Portal
Article | Year |
---|---|
Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis.
Topics: Adrenergic beta-Antagonists; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Portal Vein; Prognosis; Propranolol; Retrospective Studies; Risk Factors; Secondary Prevention; Survival Analysis; Venous Thrombosis | 2002 |
[Therapy of portal hypertension].
Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Secondary Prevention; Survival Rate | 2002 |
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Topics: Antihypertensive Agents; Ascites; Bacterial Infections; Cohort Studies; Drug Therapy, Combination; Female; Hemodynamics; Hemorrhage; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Probability; Prognosis; Propranolol; Recurrence; Risk Factors; Survival Analysis; Time Factors; Varicose Veins; Vasodilator Agents | 2003 |
"A la carte" treatment of portal hypertension or just "hors d'oeuvres".
Topics: Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Losartan; Prazosin; Propranolol | 2003 |
The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Portal Vein; Propranolol; Prospective Studies; Treatment Outcome; Ultrasonography, Doppler; Vasodilator Agents | 2005 |
[Hemorrhage due to peristomal ectopic varices: an infrequent complication of portal hypertension].
Topics: Cecal Neoplasms; Colonic Neoplasms; Diabetes Mellitus, Type 2; Duodenal Ulcer; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ileostomy; Isosorbide Dinitrate; Male; Middle Aged; Peptic Ulcer Hemorrhage; Postoperative Complications; Propranolol; Surgical Stomas; Varicose Veins | 2006 |
Effect of isosorbide dinitrate on gastric blood flow in rats with liver cirrhosis determined by analyzing gastric blood flow, portal vein pressure and blood gas.
Topics: Animals; Gastric Mucosa; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis, Experimental; Male; Oxygen; Portal Vein; Rats; Rats, Wistar; Regional Blood Flow; Thioacetamide; Vasodilator Agents; Venous Pressure | 2006 |
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Epoprostenol; Female; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Injections, Intravenous; Isosorbide Dinitrate; Lung; Male; Middle Aged; Nitric Oxide; Pulmonary Circulation; Respiratory Function Tests; Vascular Resistance; Vasodilator Agents | 2007 |
Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
Topics: Adult; Aged; Blood Pressure; Cardiac Catheterization; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Oxygen; Pulmonary Wedge Pressure; Time Factors; Vasopressins | 1983 |
Comparison of gastric mucosal blood flow in normal subjects and in patients with portal hypertension using endoscopic laser-Doppler velocimetry.
Topics: Adult; Blood Flow Velocity; Case-Control Studies; Epinephrine; Female; Gastric Mucosa; Humans; Hypertension, Portal; Isosorbide Dinitrate; Laser-Doppler Flowmetry; Liver Cirrhosis; Male; Middle Aged; Regional Blood Flow; Stomach Diseases; Vasomotor System | 1995 |
Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.
Topics: Analysis of Variance; Animals; Drug Therapy, Combination; Hemodynamics; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis, Experimental; Male; Octreotide; Portal Pressure; Portal Vein; Rats; Rats, Wistar; Regional Blood Flow; Splanchnic Circulation; Thioacetamide; Vascular Resistance; Vasoconstriction | 1994 |
The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
Topics: Adult; Aged; Azygos Vein; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Middle Aged; Vasodilator Agents | 1994 |
[Hemodynamic and functional hepatic effects of isosorbide-5-monitrate in cirrhotic patients with portal hypertension].
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis, Alcoholic; Male; Middle Aged | 1993 |
Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Renin | 1993 |
Clinical vs haemodynamic response to drugs in portal hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Octreotide; Propranolol; Recurrence; Sclerotherapy; Time Factors; Treatment Outcome; Vasodilator Agents | 1998 |
Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats.
Topics: Administration, Oral; Animals; Blood Pressure; Heart Rate; Hemodynamics; Hypertension, Portal; In Vitro Techniques; Isosorbide Dinitrate; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Portal Vein; Potassium Chloride; Rats; Time Factors | 1998 |
Effect of long-term octreotide and isosorbide dinitrate on haemodynamics in rats with portal vein stenosis.
Topics: Animals; Constriction, Pathologic; Drug Synergism; Hemodynamics; Hypertension, Portal; Isosorbide Dinitrate; Male; Octreotide; Portal Pressure; Portal Vein; Rats; Rats, Sprague-Dawley; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension.
Topics: Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Isosorbide Dinitrate; Middle Aged; Vasodilator Agents | 1999 |
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Prognosis; Vasodilator Agents | 2000 |
Isosorbide dinitrate in portal hypertensive patients.
Topics: Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis, Alcoholic | 1992 |
[Endoscopic sclerotization of esophageal varices and nitrates in the treatment of portal hypertension with bleeding esophageal varices].
Topics: Blood Pressure; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Sclerotherapy | 1991 |
Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
Topics: Aged; Blood Pressure; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Propranolol; Time Factors; Vascular Resistance | 1990 |
Effect of sublingual isosorbide dinitrate in portal hypertension.
Topics: Administration, Sublingual; Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Male; Middle Aged | 1990 |
Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
Topics: Adult; Aged; Blood Gas Analysis; Female; Hemodynamics; Humans; Hypertension, Portal; Indocyanine Green; Isosorbide Dinitrate; Kidney; Liver Circulation; Liver Cirrhosis; Male; Middle Aged | 1989 |
[The effect of peroral administration of isosorbide dinitrate on portal pressure and flow in patients with liver cirrhosis].
Topics: Administration, Oral; Blood Flow Velocity; Blood Pressure; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Portal Vein | 1988 |
Effect and mechanism of action of isosorbide-5-mononitrate.
Topics: Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Portal System | 1988 |
Effect of sublingual isosorbide dinitrate on wedged hepatic venous pressure in cirrhotics with portal hypertension.
Topics: Adult; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged | 1988 |
Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Hepatic Veins; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis, Alcoholic; Middle Aged; Splanchnic Circulation; Vascular Resistance | 1987 |
[The effect of isosorbide dinitrate (Isoket Pharma-Schwartz) in patients with liver cirrhosis].
Topics: Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Portal Vein; Regional Blood Flow | 1986 |